MedPath

Investigating the best treatment for the Delayed Sleep Phase Syndrome in adults with Attention-Deficit/Hyperactivity Disorder and it’s effect on health and appetite

Recruiting
Conditions
English: Attention-Deficit/Hyperactivity Disorder (ADHD)Delayed Sleep Phase Syndrome (DSPS)Dutch:ADHDVerlate slaapfase syndroom
Registration Number
NL-OMON22013
Lead Sponsor
Marc Blom, PhD, Director PsyQ The Hague
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
51
Inclusion Criteria

Age between 18 and 55 years old

- Diagnosis ADHD

Exclusion Criteria

- Psychotic illness

- Untreated mood disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The phase shift of the sleep/wake cycle as evaluated by the time of DLMO directly after treatment.
Secondary Outcome Measures
NameTimeMethod
Improvement of appetite hormones<br /><br>Improvement of diabetic parameters<br /><br>Improvement of biomarker profiles<br /><br>Improvement of cardiovascular parameters<br /><br>Improvement of sleep parameters<br /><br>Improvement of quality of life<br /><br>Decrease of ADHD symptoms<br /><br>Decrease of intake of carbohydrate-rich food<br /><br>Treatment satisfaction<br />
© Copyright 2025. All Rights Reserved by MedPath